Has Janet Sause received payments from drug or device companies?

Yes. Drug and device makers reported $3,835 in general payments to Janet Sause across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Janet Sause did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Janet Sause come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Janet Sause

Nurse Practitioner · Baltimore, MDNPI 1922049121

Payments from drug & device makers

$3,835in general payments, 2019–2025

Across 38 payments — averaging $100.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$496
AbbVie$357
EMD Serono, Inc.$255
Teva Pharmaceuticals USA, Inc.$254
Coloplast$217
Idorsia Pharmaceuticals US Inc$211
plus $2K from 18 others

What the payments were for

Food & beverage$3,835100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	4	$496
AbbVie	4	$357
EMD Serono, Inc.	2	$255
Teva Pharmaceuticals USA, Inc.	2	$254
Coloplast	2	$217
Idorsia Pharmaceuticals US Inc	2	$211
Novo Nordisk	2	$199
Biogen	2	$193
Boston Scientific	1	$146
Amgen	1	$125
Phathom Pharmaceuticals, Inc.	1	$123
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$121
Amarin Pharma, Inc.	1	$120
Ultragenyx Pharmaceutical Inc.	1	$118
Sanofi-aventis U.S. LLC	1	$111
Sanofi Pasteur Inc.	1	$107
Vertos Medical, Inc.	1	$107
Bayer	1	$107
Dexcom, Inc.	1	$93
Johnson & Johnson	2	$92
Nevro Corp.	1	$85
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$82
Vertex	1	$70
Solventum Corporation	1	$47

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,835 in reported general payments places this provider in the 90th percentile of 1,562 nurse practitioner providers in Maryland.

See all nurse practitioner providers in Maryland →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naloxone Hcl	20	$1,453
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	37	$187
Oxycodone Hcl	94	$127
Cephalexin	13	$75
Ciprofloxacin Hcl	12	$64
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	28	$34
Oxybutynin Chloride	15	$34

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Baltimore

Sherilyn BrinkleyBaltimore$100K
Michelle TurnerBaltimore$94K
Zeev NemirovskyBaltimore$19K
Stephanie HorrocksBaltimore$12K
Sandra WoodringBaltimore$12K
Inna BardoffBaltimore$11K
Linda RyanBaltimore$10K
Laura HostovichBaltimore$8K
Denese GaughanBaltimore$7K
Arita McCoyBaltimore$7K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →